Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
Research and development (inclusive of $2,364 and $9,966, respectively, with a related party)	$ 48,209	$ 21,753
General and administrative (inclusive of $0 and $445, respectively, with a related party)	21,361	7,579
Total operating expenses	69,570	29,332
Loss from operations	(69,570)	(29,332)
Other income (expense):
Interest expense	(1)	0
Interest income	4,041	461
Change in fair value of derivative liabilities	0	(6,393)
Other (expense) income	(1,724)	6
Total other income (expense), net	2,316	(5,926)
Net loss attributable to common stockholders	$ (67,254)	$ (35,258)
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)	$ (2.05)	$ (16.99)
Weighted average common shares outstanding, basic and diluted	32,907,100	2,075,753
Comprehensive loss:
Net loss	$ (67,254)	$ (35,258)
Other comprehensive income:
Change in unrealized gain on investments, net	614	0
Comprehensive loss	$ (66,640)	$ (35,258)